Casdin Capital’s Loxo Oncology, Inc LOXO Stock Holding History

Casdin Capital’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-360,000	Closed	-$50.4M	–	33
2018 Q4	$50.4M	Hold	360,000	–	–	8.63%	1
2018 Q3	$61.5M	Hold	360,000	–	–	7.47%	1
2018 Q2	$62.5M	Hold	360,000	–	–	8.73%	2
2018 Q1	$41.5M	Hold	360,000	–	–	7.3%	1
2017 Q4	$30.3M	Hold	360,000	–	–	7.38%	3
2017 Q3	$33.2M	Hold	360,000	–	–	9.36%	1
2017 Q2	$28.9M	Hold	360,000	–	–	10.68%	1
2017 Q1	$15.1M	Hold	360,000	–	–	8.94%	3
2016 Q4	$11.6M	Buy	360,000 +69,000	+24%	+$1.77M	9.55%	2
2016 Q3	$7.62M	Sell	291,000 -9,000	-3%	-$235K	6.17%	6
2016 Q2	$6.95M	Buy	300,000 +50,000	+20%	+$1.24M	6.92%	5
2016 Q1	$6.83M	Sell	250,000 -1,500	-0.6%	-$31.4K	7.85%	1
2015 Q4	$7.16M	Buy	+251,500	New	+$6.75M	6.32%	3

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Casdin Capital's LOXO Position: Q1 2019 in Review

Casdin Capital sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 360,000 shares — an estimated $50.4M sold.

Casdin Capital first reported a position in LOXO in Q4 2015 and held it in 13 quarters. The position peaked at $62.5M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Casdin Capital reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Casdin Capital sold 360,000 Loxo Oncology, Inc shares in Q1 2019, an estimated $50.4M.
Casdin Capital first reported a position in Loxo Oncology, Inc in Q4 2015 and held it in 13 quarters.
Casdin Capital's Loxo Oncology, Inc position peaked at $62.5M in Q2 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Casdin Capital's 13F filing for Q1 2019, filed 15 May 2019.